Proliferation of c-myc overexpressing lymphomas is reduced by HDAC inhibition, and it has been demonstrated in osteosarcoma cells that chromatin-modifying drugs such as vorinostat can increase miRNA expression that leads to decreased c-myc protein and induction of apoptosis [31,34]. Here, MYC is linked to osteosarcoma.